Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.Saroj Vadhan‐Raj, Susan E. Krown, Mathilde Krim et al.|PubMed|1986Cited by 107
Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factorsSusan E. Krown, Herbert F. Oettgen, Saroj Vadhan‐Raj et al.|Cancer|1986Cited by 84
American cancer society Phase I trial of naturally produced beta-interferon.Michael Hawkins, Herbert F. Oettgen, Susan E. Krown et al.|PubMed|1984Cited by 26
RECOMBINANT LEUKOCYTE A INTERFERON IN KAPOSI'S SARCOMA<sup>a</sup>Susan E. Krown, Herbert F. Oettgen, Francisco X. Real et al.|Annals of the New York Academy of Sciences|1984Cited by 24
Interferons and Other Biological Response Modifiers in the Treatment of Kaposi�s Sarcoma1Susan E. Krown, Herbert F. Oettgen, Patricia L. Myskowski et al.|Frontiers of radiation therapy and oncology|2015Cited by 7